NanoViricides Inc. Shares Close the Week 6.7% Lower - Weekly Wrap
The company saw its shares close the week 6.7% lower than last week, with trading volume lower than its 30 day average.
Jan 12, 2022 by Kwhen Finance Editors
NanoViricides Inc. (NNVC) shares closed this week 6.7% lower than it did at the end of last week. The stock is currently down 14.2% year-to-date, down 2.4% over the past 12 months, and down 88.1% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%.
Trading Activity
- Shares traded as high as $3.92 and as low as $2.97 this week.
- Trading volume this week was 48.2% lower than the 10-day average and 59.5% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| NanoViricides Inc. | -1.3 | -14.2 | -2.4 | -65.2 | 2.0 |
| Dow Jones Industrial Average | 0.5 | -0.2 | 18.9 | -2.4 | 22.8 |
| S&P 500 Index | 0.9 | -1.1 | 25.7 | -3.1 | 28.0 |
| Health Care | 0.8 | -3.5 | 14.4 | -4.7 | 22.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -981.5%
- The company's stock price performance over the past 12 months lags the peer average by -128.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| NanoViricides Inc. | NNVC | 0 | -14.2 | -2.4 | -65.2 | 2.0 |
| Peer Avg | N/A | 0.8 | 1.6 | 8.5 | -22.1 | 78.4 |
| Merck & Co Inc | MRK | 28.7 | 6.6 | -0.4 | -8.9 | 452.9 |
| Bristol-Myers Squibb Co. | BMY | -26.9 | 5.9 | 4.1 | -5.7 | 22.6 |
| Glaxosmithkline plc - ADR | GSK | 17.4 | 1.7 | 23.7 | -0.4 | 38.4 |
| Gilead Sciences, Inc. | GILD | 12.3 | -0.3 | 20.7 | ||
| Novavax, Inc. | NVAX | -9.5 | -5.6 | 10.8 | -59.5 | 19.4 |
| Biocryst Pharmaceuticals Inc. | BCRX | -11.7 | 6.7 | 91.0 | -22.2 | 90.5 |
| Chimerix Inc | CMRX | -3.8 | -1.2 | -27.9 | ||
| NovaBay Pharmaceuticals Inc. | NBY | 0 | -0.7 | -53.7 | -79.8 | 3.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: